Weekly News – October 27

Thank you for making the CRC Allocators Conference a Success

WeWork battles looming

Exclusive Content

Find it here

Featured Content:
Barclays takes on double-dips

Featured Content

Find it here

This is phenomenal content analyzing the latest wave of LME transactions
Is the double dip here to stay?

FAs start your pitchingâ€¦

No need to thank us.
Just sponsor our curated content!Â

Exclusive Content:
Make Wholes & Hertz

Exclusive Content

Find it here on CreditSights

Air Methods files for BK

Exclusive Content

Find it on Reorg here

Evergrande tightrope

Crypto bull run

Genesis going it alone

Purdue briefing complete

Oral argument scheduled for December 4, 2023
Find the briefs here

A potent debt mixture is brewingâ€¦

Leading to some cracks in credit

CRC Allocators Conference

This event is available to institutional investors only

Featured Event: Beard Investing Conference

CRC weighs in on Serta

The Academics Speak Up
Purdue Pharma

Purdue Pharma is the gift that keeps on giving. This is our third installment on the twists and turns this case has taken through the Courts. You can read our first installment here, and our second here.

All bets came off the table when the Supreme Court decided to reshuffle the deck by taking on the appeal of the 2nd Circuitâ€™s decision. Not only did SCOTUS take the unusual step of taking on this big ticket issue in BK cases but it also stopped the lower courtâ€™s decision in its tracks putting the breaks on the entire enchilada. We decided to consult with our expert Academic Contributors for our inaugural feature the Academics Speak Up to get their takes on the latest developments.

We are excited to bring you the varying perspectives of Prof. Tony Casey, Prof. Samir Parikh and Prof. Ralph Brubaker.

Read on here, you wonâ€™t be disappointed.

Read more on Purdue Pharma